We have two core business segments, one focused on supply chain authentication across multiple industries. The second is focused on large scale linear DNA production for diagnostics and vaccines.
Location: United States, New York
Employees: 51-200
Total raised: $6M
Founded date: 1983
Investors 1
| Date | Name | Website |
| - | 3A Venture... | 3aventures... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 12.10.2020 | - | $1M | - |
| 08.11.2016 | - | $5M | - |
Mentions in press and media 17
| Date | Title | Description |
| 08.03.2024 | Anti-counterfeit Packaging Market to Surpass USD 426.10 Billion by 2030, Empowering Brand Protection | Anti-counterfeit Packaging Market share Anti-counterfeit packaging market sees rapid growth driven by global need to combat counterfeiting in diverse industries. AUSTIN, TEXAS, USA, March 8, 2024 /EINPresswire.com/ -- The SNS Insider report... |
| 14.07.2023 | Applied DNA Acquires Spindle Biotech | Applied DNA Sciences (NASDAQ:APDN), a New York-based company which specializes in PCR-based DNA technologies, acquired Spindle Biotech, a Toronto, Canada-based biotech company developing RNA manufacturing technologies. Under the terms of th... |
| 11.02.2022 | Applied DNA Sciences : APDN FQ1'22 Financial Results Feature Record Quarterly Revenues | Applied DNA Sciences First Quarter Fiscal 2022 Financial Results Feature Record Quarterly Revenues - Revenues of $4.2 Million Increased 158% Year-over-Year and 37% Sequentially - - Momentum Continues into FQ2 with January Revenues of Approx... |
| 04.01.2022 | Applied DNA Sciences : APDN Receives NYS Dept of Health Conditional Approval for Linea™ 2.0 | Applied DNA Receives New York State Department of Health Conditional Approval for Linea™ 2.0 COVID-19 Assay as Laboratory Developed Test Company Also Announces Intention to File Near-Term EUA Request with FDA for Linea 2.0 Assay and Recentl... |
| 29.11.2021 | Applied DNA Sciences : APDN Strategy to Address Omicron SARS-CoV-2 Variant | Applied DNA Announces Strategy to Address Omicron SARS-CoV-2 Variant, Introduces Linea™ 2.0 COVID-19 Assay Kit Linea™ COVID-19 Assay Kit Likely Subject to Unique Double S-Gene Target Drop, Enables Rapid Reflex Testing of Positive Samples to... |
| 09.11.2021 | Research Publication Demonstrates Utility of Applied DNA's LinearDNA™ in Non-Viral CAR T Manufacturing | Research Publication Demonstrates Utility of Applied DNA's LinearDNA™ in Non-Viral CAR T Manufacturing Systems Preclinical Study Details Application of LinearDNA Suitable for the Cost-Effective Production of CAR T Cells Results Demonstrate ... |
| 20.10.2021 | Applied DNA Sciences : Ganesha Ecosphere to Deploy CertainT® for Recycled Polyester | Ganesha Ecosphere and Applied DNA to Deploy CertainT® Platform to Secure Recycled Polyester Supply Chain STONY BROOK, New York, and KANPUR, India - October 20, 2021 - Applied DNA Sciences, Inc. (NASDAQ: APDN) (Applied DNA or the "Compa... |
| 27.09.2021 | Applied DNA Sciences : APDN Receives Purchase Orders Totaling $1.6 Million to Tag Textile Fibers | Applied DNA Receives Purchase Orders Totaling $1.6 Million to Tag Textile Fibers Company Progressing Textile Projects Representing New Commercial Opportunities Catalyzed by Brands and Suppliers Prioritizing Their Commitment to Labor Rights,... |
| 14.09.2021 | Applied DNA Sciences : CertainT® Platform Support for TruTrace StrainSecure™ 2.0 | Applied DNA Announces CertainT® Platform Support for TruTrace StrainSecure™ 2.0 for Next Generation Cannabis Tagging, Testing and Tracking Advances Partnership Aimed at Streamlining Cannabis and CBD Cultivator Production, Safety Standards, ... |
| 08.09.2021 | Applied DNA Sciences : Enters into MSA with Flora Growth for Cannabis Validation and Authentication | Applied DNA Enters into Master Services Agreement with Flora Growth for Cannabis Validation and Authentication, Secures First Statement of Work Contract CertainT® Integration with TruTrace StrainSecure™ Platform to Power Flora Growth's Glob... |
Show more